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ABSTRACT
Objective: To evaluate the effect of Chinese phytotherapy to reduce stress levels, anxiety 
and improve quality of life. Method: double-blind randomized controlled trial with 89 
volunteers divided into three groups: control (no intervention), Placebo and Phytotherapy. 
The study was conducted in 2015 with healthy adults treated at the Integrated and Eastern 
Therapy Institute, in Sao Paulo, Brazil. Participants were evaluated at baseline and after 
three weeks with the Stress Symptoms List (SSL), Anxiety Inventory-Trait and State 
and SF12v2 for quality of life. Intervention groups received a placebo or Gan May 
Zao formula (GMDZ) flask with 50 ml. Results: According to ANOVA, there were 
significant differences (p = 0.025) after treatment of stress (SSL2). And the difference 
was between control and Phytotherapy groups, according to the Tukey post hoc (p = 
0.022). There were no differences in the levels of state-anxiety and physical and mental 
domains in the SF12v2. Conclusion: The GMDZ formula reduced stress levels, but more 
studies are needed with greater sample, with reassessment of dosage and a longer period 
of treatment to confirm and extend the results. Brazilian Registry of Clinical Trials: 
RBR-28s4hz.
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INTRODUCTION
Stress is present in the daily lives of people in at least 
90% of the population(1) and it is known that continuous 
stress can cause numerous pathophysiological effects on 
physical and mental health and can lead to disorders such 
as depression and anxiety(2). Oriental therapies seek, above 
all, to promote wellness and prevent diseases, with benefits 
for early intervention through the combination of therapies 
and customizing the service(3).
In fact, the “Strategy of the World Health Organization 
(WHO) on Traditional Medicine 2014-2023” set as one 
of its goals, the expansion of the use by State Members, 
regarding Traditional Chinese Medicine knowledge to 
improve the health, well-being of populations and the 
patients centered outcome. The development of research 
on safety and efficacy of the techniques for incorporation 
of products, professional and therapeutic in public health 
systems of different countries was emphasized as criti-
cal(4). In this sense, the use of phythotherapy has been sug-
gested in the treatment of most different conditions and 
diseases for millennia in China(5), but the assessment of the 
effects and mechanisms of action need to be further studied 
and recognized.
In 2005, the WHO global survey on the National Policy 
on Traditional Medicine and Phytotherapy Regulations had 
already shown an increase in the use of complementary 
and alternative medicine in many developed and develop-
ing countries. The safety and efficacy of such practices and 
quality control have become important concerns. Thus, the 
preparations of Chinese formulas have followed the stan-
dard of Good Practice in Chinese Medicine(6).
The decoction Gan Mai Da Zao (GMDZ) is a Chinese 
formula widely used for depression in East Asia(7) and has 
been commonly recognized as a safe and effective prescrip-
tion for the treatment of these mental disorders in China(8). 
It has also demonstrated to have a protective effect on 
biochemical alterations in the chronic mild stress induced 
in mice, and decreased levels of glutamate and increasing 
NMDA receptor expression in the NR2a and NR2b subunit 
in the frontal cortex and hippocampus in stressed mice(9).
According to Traditional Chinese Medicine (TCM), 
the GMDZ formula is suitable for TCM diagnoses, such 
as irritability syndrome of Zhang organs due to blood 
deficiency in the Heart (Xin) and Stagnation of Liver Qi 
(Gan): for the symptoms irritability, anxiety, depressive epi-
sodes followed by crying, insomnia, sleepwalking, epilepsy 
and neurasthenia. The tongue in general appears red with 
little coating and fast and fine pulse(10).
The ingredients of Gan Mai Da Zao include the fol-
lowing herbs: Radix Glycyrrhiza uralensis Fisch (Licorice – 
Gan Cao), Triticum aestivum Levis (Wheat – Fu Xiao Mai) 
and Fructus Zizyphus Jujubae ( Jujube – Da Zao). Radix 
Glycyrrhizae (Gan Cao) has a sweet and neutral taste, it 
nourishes the Qi, the Heart and the Spleen (Pi), eliminat-
ing spasms. Wheat (Fu Xiao Mai) has a sweet and salty 
taste of fresh nature and it nourishes Heart Yin and har-
monizes the mind. The Fructus Zizyphi or jujube (Da Zao) 
is sweet, has warm nature tones Middle Burner, it nourishes 
the Blood and the Qi, relaxes and harmonizes the liver, as 
well as moisturizing the Zang (viscera). Therefore, the main 
actions of GMDZ are: nourishment of the heart, calming 
the Shen, harmonizing Jiao Medium, toning the Spleen Qi 
and calming the impatience(11).
With regard to stress, this is not necessarily negative, 
since it is a common event of daily life and all organisms 
have developed mechanisms to deal with it. Besides that, 
it can be stimulating and motivating. The problem is its 
intensity, length and when it exceeds the individual’s abil-
ity to adapt. According to neurobiology of stress, there is a 
response to the stressor element characterized by four main 
aspects: avoidance behavior, increased surveillance, activa-
tion of the Sympathetic Vegetative Nervous System, and 
finally release of cortisol by the adrenal glands(12).
When excessive, stress causes an imbalance in the neu-
ral circuit that interferes with cognition, decision making, 
anxiety and mood, creating changes in behavioral states. 
Exposure to continuous stress leads to numerous physiolog-
ical effects, with the activation of neuroendocrine functions 
in adrenal, limbic, hypothalamic and pituitary systems(13-14) 
and hormonal functions, with the release of corticoste-
roids(15). The hormone cortisol, in turn, is released by the 
adrenal gland cortex in response to increased blood levels of 
adrenocorticotropic hormone (ACTH), which is released by 
the anterior pituitary in response to corticotropin releasing 
hormone (CRH). When the information reaches the region 
of the basolateral amygdala, it is processed and transmitted 
to the central nucleus neurons. Upon reaching the nucleus, 
the stress response leads to an inappropriate activation of 
the amygdala, which may be related to anxiety episodes. We 
should consider that continuous exposure to cortisol can 
lead to dysfunction and death of hippocampal neurons, cre-
ating a vicious circle in which the stress response becomes 
more pronounced, leading to increased cortisol release and 
further damage to the hippocampus(12).
Finally, stress interferes with quality of life and can 
change the way a person reacts to different areas of his or 
her life. The quality of life is related not only to the health 
field, but also the social, emotional and professional area. 
In 1947, the WHO defined health as a state of physical, 
mental and social well-being and not merely the absence 
of disease or disease and thus, introducing the idea of qual-
ity of life, emphasizing its multidimensional character(16). 
The quality of life was defined, therefore, as the perception 
of individuals of their position in life, in cultural context 
and value system in which they live, and in relation to their 
goals, expectations, standards and concerns(17).
Due to the above, this study was conducted to compare 
the effects of Gan Mai Da Zao in a Control group and 
a placebo group, in reducing levels of stress, anxiety and 
improving quality of life. The experiment was conducted 
in healthy subjects, which showed moderate to high levels 
of stress and anxiety cared at the Integrated and Eastern 
Therapy Institute in the city of Sao Paulo. We also sought 
to evaluate the symptoms that best responded to treatment 
and possible TCM diagnoses related to the symptoms.
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METHOD
This is a parallel, double-blind, randomized controlled 
trial. The research was conducted in an outpatient clinic at 
Integrated and Eastern Therapy Institute (IETI) from June 
to August 2015. We invited volunteers from IETI to par-
ticipate in the study that had medium and high levels of 
stress, according to the Stress Symptoms List (LSS, 37-120 
points). Pregnant women, individuals who were on holi-
day leave during the research period were excluded; we also 
excluded those who started using allopathic medicines for 
anxiety and antidepressants or initiate other energy thera-
pies during the research. However, we did not exclude those 
already performing psychological therapy, with the condi-
tion to continue their treatment normally.
After participants’ inclusion, a random division was made 
in three different groups, using the Research Randomizer 
Quick Tutorial program control group – G1 (no interven-
tion), Placebo Group – G2, Phytotherapy Group - G3 The 
Phytotherapy and placebo groups received one Chinese 
herb bottle or placebo and took 15 drops three times a day, 
dissolved in water, in the morning, afternoon and evening, 
for the period of 3 weeks. The flasks were previously pre-
pared by a compounding pharmacy and all containers were 
equal and received a number (1 or 2) to allow the blinding 
of both for participants as well as for the researcher.
The sample size calculation was originally proposed for 
90 individuals with a power of 80% and 95% confidence 
interval. However, the eligible population obtained was 89 
individuals and 71 completed the study. Regarding losses, 
14 did not attend the second assessment or failed to main-
tain the regularity of the use of Phytotherapy or placebo; 
two began acupuncture therapy and two were on Holydays 
at the same period (Figure 1).
All participants answered a biologic sociodemographic 
questionnaire and instruments: Stress Symptoms List 
(LSS)(18), State-Trait Anxiety Inventory(19) and SF12v2 for 
Quality of life(20), applied at the beginning of the research 
and after three weeks of treatment.
Eligibility  criteria (n =105)
Excluded (n = 16)
Participants did not fill in eligibility criteria
(n = 10)
Desistiram de participar (n = 6)
Placebo (G2)
(n = 30)
Randomized (n = 89)
Alocation
Control (G1)
(n = 29)
Loss of follow-up (did not
answer) (n = 9)
Phytotherapy (G3)
(n = 30)
Follow-up
Loss of follow-up (n = 2)
Holidays (n = 2)
Loss of follow-up (n = 3)
Started other therapies (n = 2)
Analyzed (n = 20) Analyzed (n = 26) Analyzed (n = 25)
Analisys
Figure 1 – Flowchart of participants involved in the study - Sao Paulo, SP, Brazil, 2015.
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As a protocol for Phytotherapy group we used GMDZ 
formula consisting in three herbs: (1) Radix Glycyrrhiza 
uralensis Fisch (Licorice – Gan Cao), (2) Triticum aestivum 
Levis (Wheat – Fu Xiao Mai) and (3) Fructus zizyphus 
Jujubae ( Jujube – Da Zao). The control group received 30% 
alcoholic solution (Mineral Water, brandy), basis generally 
used for herbal composition formulas.
The study met the resolution 466/12 of the Brazilian 
National Health Council for research involving human 
subjects, participants signed the Informed and Consent 
form. We offered the opportunity to receive Chinese 
Phytotherapy after the conclusion of the research to the 
participants in the control and placebo groups. The research 
project was approved by the Research Ethics Committee 
of the School of Nursing of the Universidade de São Paulo 
(No. 1,105429) and it was registered by the Brazilian 
Registry of Clinical Trials (No. RBR-28s4hz).
For descriptive analysis of the data, we used central 
tendency and absolute and relative frequencies, Cronbach’s 
alpha to assess the reliability of the scales used and for com-
parison of groups, we used ANOVA for repeated measures 
with Tukey post-hoc. We also used the Cohen’s d index to 
measure the effect size.
RESULTS 
The mean age of participants was 37 years (±11.4), 69.0% 
(49) were female, 66.2% (47) were single, 73.2% (52) had 
college education, 74.6% (53) with no history of prior disease 
and high levels of stress (67.7±19.3). Some comorbidities were 
reported as: osteoarthritis (2), back problems (2), the patellar 
chondromalacia (1), depression (2), dermatitis (1), sinusitis 
(1), bronchitis (1), diabetes mellitus (1), gastritis (2), panic (1), 
and postsurgical sequelae (1). Two (2.8%) participants were 
on psychological therapy during the period of investigation.
There was homogeneity in the distribution between the 
study groups regarding age, gender, stress levels, people with 
and without pre-conditions, marital status and educational 
level (p > 0.05).
Table 1 presents the descriptive measures of the scores 
obtained in the LSS, STAI, physical domain (SF12P), men-
tal domain (SF12M) before (1) and after treatment (2) and 
comparative analysis between groups (ANOVA).
Table 1 – Descriptive means and standard deviation levels of stress, STAI and physical domain (SF12P), mental domain (SF12M) before 
and after treatment in the three groups and intergroup ANOVA - Sao Paulo, SP, Brazil, 2015.
Instruments Groups n mean SD p
LSS-1
Control 20 67.1 15.5
Placebo 26 69.5 23.4
Phytotherapy 25 66.2 17.8
ANOVA 71 67.7 19.3 0.821
LSS-2
Control 20 70.4 15.5
Placebo 26 58.1 25.1
Phytotherapy 25 54.0 17.2
ANOVA 0.025*
STAI S-1
Control 20 50.2 11.1
Placebo 26 51.7 12.4
Phytotherapy 25 51.1 10.3
ANOVA 0.900
STAI S-2
Control 20 50.4 11.1
Placebo 26 45.8 10.9
Phytotherapy 25 47.2 11.2
ANOVA 0.374
SF12 P-1
Control 20 48.3 10.1
Placebo 26 50.3 9.4
Phytotherapy 25 47.7 8.8
ANOVA 0.588
SF12 P-2
Control 20 48.4 11.2
Placebo 26 52.5 7.6
Phytotherapy 25 49.8 7.8
ANOVA 0.271
continued...
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The result of Cronbach’s alpha test for LSS was 0.92; 0.94 
for state-anxiety and 0.88 for trait-anxiety. At baseline, the 
mean score of trait-anxiety was 47.9 and state-anxiety was 
51.1, both considered moderate level of anxiety. For LSS, 
the baseline mean was 66.7 (high stress level), the physical 
domain of the SF12 was 48.8 and mental domain was 37.1. It 
has been recommended for this instrument that the interpre-
tations should be based on means considered normal score in 
US healthy population of 50 and a standard deviation of 10(20).
In the analysis of repeated measures (ANOVA), there 
was a statistically significant difference (p = 0.025) in the 
assessment of LSS after treatment and this difference 
occurred only between control and Phytotherapy groups, 
according to the Tukey post hoc (p = 0.022). There were no 
differences in the levels of state-anxiety (STAI S) and physi-
cal and mental domain of SF12 between any of the groups. 
The trait-anxiety, on the other hand, was not evaluated at the 
end of the study. It is understood that the trait-anxiety is a 
relatively stable and permanent feature in the individual(19).
Also Cohen index d for the three groups and the per-
centage change for all three groups were defined between 
before and after treatment. The placebo group reached 
16.0% reduction, with Cohen’s d index 2.4 (great effect) and 
Phytotherapy Group reached 18.0% reduction, with Cohen 
index d 3.5 (great effect).
ANOVA was performed for repeated measures and 
multiple Tukey comparisons between before-after treatment 
for each LSS symptoms (Table 2) and only the symptoms 
presented in Table 2 showed statistical differences between 
before and after treatment.
The symptoms that best responded to the treatment of 
Phytotherapy were: “I feel nausea” (68.0% reduction), “my 
appetite fluctuates a lot” (41.0%), “I forget things” (18.0%) 
“I feel physical exhaustion” (28.0%) and “I have night-
mares” (28.0%). The reduction of symptoms “I forget things” 
(18.0%) and “I have nightmares” (28.0%) was observed only 
in phytotherapy group.
The symptoms that responded only to Placebo were: 
“everything terrifies me” (32.0%) and “I worry” (25.0%). The 
symptom “I feel nauseous” also responded to the placebo 
group with 18.0% and “my appetite fluctuates a lot” with 
23.0% reduction.
The side effects observed with the use of GMDZ were 
mild bloating, acid regurgitation and somnolence. But that 
was no reason for participants to leave the study.
DISCUSSION
Positive results were found for Phytotherapy Group 
regarding the stress levels. As already noted, the GMDZ for-
mula has three components, including Licorice (Gycyrrhiza). 
Studies on Licorice (Gycyrrhiza) or Gan Cao (Glycyrrhiza 
uralensis) indicate that the main active ingredient is the 
glycyrrhizic acid(21), a potent inhibitor of 11b-hydroxyster-
oid dehydrogenase (11b-HSD1 and 11b-HSD2). These 
isoenzymes are fundamental in cortisol metabolism(22), 
which in turn is associated with an increased propensity to 
develop distress and depression. Another herb, the fruit of 
the jujube (Ziziphus jujube), is also widely used in China 
for treating insomnia and anxiety. Its main bio-component 
Jujubogenina, which the main component is Jujuboside A 
( JuA). Studies indicate that JuA has direct action on the 
glutamatergic system in the hippocampus through the inhi-
bition of glutamate via modulation of CaM kinase(23), which 
implies a quick action against deleterious effects of stress.
...continuation
Instruments Groups n mean SD p
SF12 M-1
Control 20 39.2 13.3
Placebo 26 35.9 10.5
Phytotherapy 25 36.8 10.8
ANOVA 0.618
SF12 M-2
Control 20 40.3 12.2
Placebo 26 41.0 12.9
Phytotherapy 25 42.3 11.3
ANOVA 0.848
*p < 0.05 (ANOVA for repeated measures).
Table 2 – Stress symptoms between groups, according to p values by ANOVA and Tukey, and Cohen index d - Sao Paulo, SP, Brazil, 2015. 
ANOVA
P
Tukey
p
G2 – G1
Cohen’s d (%)
G3 – G1
Cohen’s d (%)
Everything frightens me 0.031 G2-1 (0.023) 0.42 (33.0) -
I feel nausea 0.000 G2-1 (0.004); G3-1(0.000) 0.17 (19.0) 0.8 (68.0)
I forget things 0.006 G3-1 (0.004) - 0.29 (18.0)
I feel physical exhaustion 0.031 G2-1(0.049); G3-1 (0.05) 0.36 (23.0) 0.68 (28.0)
I worry 0.031 G2-1 (0.028) 0.69 (26.0) -
I have nightmares 0.042 G3-1(0.035)  - 0.28 (28.0)
My appetite fluctuates a lot 0.003 G2-1(0.004); G3-1(0.000) 0.28 (23.0) 0.36 (41.0)
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According to the ERM, the treatment reduced the levels 
of various symptoms related to the Heart (Xin), such as for-
getting (d = 18.0%) and nightmares (d = 28%) for Group 3. 
These may be related to deficiency of Qi and Xue (blood) 
from the Heart and consequent disturbance of the Shen 
(Mind). In fact, all the Yin organs may be involved. As the 
Heart (Xin), the Spleen (Pi) can be damaged by overwork 
or concerns(24). Symptoms related to deficiency of Qi and 
Xue (Blood) Spleen (Pi) which obtained a reduction after 
treatment were nausea (d = 68%) and oscillating appetite 
(d = 41%). Fire derived from Liver Qi may also be involved 
in the failure of Yin, with the appearance of nightmares. And 
finally, if there is Kidney failure (Shen) and Lungs failure 
(Fei) emerge the general weakness of Qi and Yin(25), affect-
ing all systems, causing the individual to feel exhaustion, 
which was decreased by 28.0% in the phytotherapy group.
In contrast, the placebo group also achieved good results in 
some mental and physical symptoms. Psychological symptoms 
of “everything terrifies me” and “I worry” reached 32.0% and 
35.0% reduction respectively; and physical symptoms, “I feel 
nausea” (d = 19.0%), “I feel physical exhaustion” (d = 23.0%) 
and “oscillating appetite” (d = 23%) were also reduced, which 
led to an inevitable question. Why did a placebo solution 
produce positive effects on the reduction of symptoms? Could 
the effects be kept in a longer treatment time?
For many years, placebos were defined by their inert 
content being used as a control mechanism in clinical tri-
als and treatments in clinical practice. Recent studies show, 
however, that the placebo effects are Psychobiological 
events attributable to the overall therapeutic context, and 
that such effects can be robust in clinical and laboratory 
settings(26). To understand the placebo phenomenon, it is 
necessary to differentiate it from other non-specific fac-
tors, such as: the natural course of the disease, fluctuations 
in symptoms, regression to the mean, the time of the dis-
ease, a subjective response bias of the patient, among oth-
ers. Although it lacks a specific pharmacological effect, it 
is known today that placebos may act therapeutically and 
impact patient’s imagination, beliefs, expectations, emotions 
and past experiences(27).
There are neurobiological and psychological mecha-
nisms involved in the placebo effect and there are two 
main theoretical structures proposed to explain it: (1) the 
mentalistic theory, according to which the expectation of 
the individual is the main basis for the placebo effect, and 
(2) the conditioning theory, which indicates that placebo 
is essentially the result of previous experiments and results 
of associative learning processes (conditioned response)
(26). Based on this, we question whether the belief of the 
participants in the benefits and feel cared were determi-
nants in producing the effects, even if they knew which 
groups receive a placebo solution. In fact, an affective 
communication (warmth, empathy, eye contact), as offered 
in customer service can produce satisfaction, patient com-
pliance and positive effects on health, regardless of a medi-
cation or procedure performed(28).
Given the complexity of the placebo effect, it would 
have been important to assess how much they thought 
they were taking the real drug or placebo. In this sense, to 
understand how expectations can be crucial, a study was 
carried out with a radically different approach to Parkinson’s 
patients for the management of pain and anxiety. The objec-
tive of the study was to recognize the administration and 
withdrawal of drugs open or closed so patients could pro-
duce a different effect with respect to the usual medica-
tions of pain and anxiety, offered intravenously. And it was 
concluded that, in fact, open and informed treatment, with 
patients aware of medications to which they were being 
subjected achieved better results than those completely 
unaware patients receiving medications(29).
The placebo effect seems to act on various neurotrans-
mitter systems, such as opioid and dopamine. Brain regions 
including anterior cingulate cortex, dorsolateral prefrontal 
cortex and basal ganglia can be activated after placebo 
administration. The expected improvement in a patient may 
therefore influence the results, as well as some active inter-
vention, and this effect may be greater for procedures(30).
Some considerations need to be made in relation to the 
limitations of this study. Perhaps the three weeks’ period 
was relatively short to achieve the desired results and the 
proposed dosage, consisting of only 15 drops three times 
daily may be insufficient to reduce anxiety and improve 
quality of life. The main limitation of this study was the 
number of people who managed to complete the study. We 
did not reach the expected number (30) per group, deter-
mined by sample size calculation and the findings should 
be carefully considered.
CONCLUSION
The results suggest that stress levels were reduced with 
the use of GMDZ formula compared to the control group, 
although no differences were found between Phytotherapy 
and Placebo Group. There was no intergroup differences 
in the levels of anxiety-state and quality of life (SF12). For 
symptoms of stress that improved after treatment with 
GMDZ, it is suggested that the formula is indicated for the 
TCM diagnostics association: Heart Deficiency (Xin) and 
Shen Perturbation (mind), Qi Stagnation of Liver (Gan) 
for Qi deficiency and Blood Spleen (Pi) and Qi deficiency 
and Yin General. However, more studies are needed with 
a greater sample size, a reassessment of the dosage, the 
period of treatment and the use of physiological markers of 
stress, so that the results may be confirmed and extended to 
other populations.
RESUMO
Objetivo: Avaliar o efeito da fitoterapia chinesa na redução de níveis de estresse, ansiedade e melhoria de qualidade de vida. Método: 
Ensaio clínico randomizado duplo-cego, com 89 voluntários divididos em três grupos: Controle (sem intervenção), Placebo e Fitoterapia. 
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Foi realizado em 2015, com adultos saudáveis atendidos no Instituto de Terapia Integrada e Oriental, São Paulo. Foram avaliados no 
baseline e, após 3 semanas, pela Lista de Sintomas de Stress (LSS), Inventário de Ansiedade-Traço e Estado e o SF12v2 de qualidade 
de vida. Os grupos de intervenção receberam um frasco de 50 ml de placebo ou da fórmula Gan Mai Da Zao (GMDZ). Resultados: 
Segundo ANOVA, houve diferença (p = 0,025) no pós-tratamento de estresse (LSS2). E a diferença foi entre os grupos Controle 
e Fitoterapia, de acordo com o post hoc de Tukey (p = 0,022). Não houve diferenças nos níveis de ansiedade-estado e domínio físico 
e mental do SF12v2. Conclusão: A fórmula GMDZ reduziu os níveis de estresse, mas são necessários mais estudos com amostra 
significativa, com reavaliação da posologia e um período maior de tratamento para confirmar e ampliar os resultados. Registro Brasileiro 
de Ensaios Clínicos: RBR-28s4hz.
DESCRITORES
Fitoterapia; Estresse Psicológico; Ansiedade; Medicina Tradicional Chinesa.
RESUMEN
Objetivo: Evaluar el efecto de la fitoterapia china en la reducción de los niveles de estrés, ansiedad y mejoría de calidad de vida. Método: 
Ensayo clínico aleatorizado, doble ciego, con 89 voluntarios divididos en tres grupos: Control (sin intervención), Placebo y Fitoterapia. 
Se realizó en 2015, con adultos sanos atendidos en el Instituto de Terapia Integrada y Oriental, São Paulo. Fueron evaluados en el 
baseline y, después de 3 semanas, por el Listado de Síntomas de Estrés (LSE), Inventario de Ansiedad Rasgo-Estado y el SF12v2 
de calidad de vida. Los grupos de intervención recibieron un frasco de 50 ml de placebo o la fórmula Gan Mai Da Zao (GMDZ). 
Resultados: Según ANOVA, hubo diferencia (p = 0,025) en el post tratamiento de estrés (LSE2). Y la diferencia fue entre los grupos 
Control y Fitoterapia, de acuerdo con el post hoc de Tukey (p = 0,022). No hubo diferencias en los niveles de ansiedad-estado y dominio 
físico y mental del SF12V2. Conclusión: La fórmula GMDZ redujo los niveles de estrés, pero son necesarios más estudios con muestra 
significativa, con reevaluación de la posología y un período mayor de tratamiento para confirmar y ampliar los resultados. Registro 
Brasileño de Ensayos Clínicos: RBR-28s4hz.
DESCRIPTORES
Fitoterapia; Estrés Psicológico; Ansiedad; Medicina China Tradicional. 
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